Vanguard Fiduciary Trust
VIR icon

Vanguard Fiduciary Trust’s Vir Biotechnology VIR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.58M Buy
841,557
+109,836
+15% +$1.04M ﹤0.01% 1894
2026
Q1 		$6.56M Buy
+731,721
New +$5.83M ﹤0.01% 1937

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Fiduciary Trust's VIR Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Vir Biotechnology (VIR) stake by 15% in Q2 2026, buying an estimated $1.04M and bringing the position to 841,557 shares worth $8.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

Vanguard Fiduciary Trust first reported a position in VIR in Q1 2026 and has held it in 2 quarters since. 236 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Vanguard Fiduciary Trust held 841,557 shares of Vir Biotechnology worth $8.58M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 109,836 Vir Biotechnology shares in Q2 2026, an estimated $1.04M.
  • Vir Biotechnology made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1894 holding.
  • Vanguard Fiduciary Trust first reported a position in Vir Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 236 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.